» Articles » PMID: 21837324

A High-performance Microsystem for Isolating Circulating Tumor Cells

Overview
Journal Lab Chip
Specialties Biotechnology
Chemistry
Date 2011 Aug 13
PMID 21837324
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

A unique flow field pattern in a bio-functional microchannel is utilized to significantly enhance the performance of a microsystem developed for selectively isolating circulating tumor cells from cell suspensions. For high performance of such systems, disposal of maximum non-target species is just as important as retention of maximum target species; unfortunately, most studies ignore or fail to report this aspect. Therefore, sensitivity and specificity are introduced as quantitative criteria to evaluate the system performance enabling a direct comparison among systems employing different techniques. The newly proposed fluidic scheme combines a slow flow field, for maximum target-cell attachment, followed by a faster flow field, for maximum detachment of non-target cells. Suspensions of homogeneous or binary mixtures of circulating breast tumor cells, with varying relative concentrations, were driven through antibody-functionalized microchannels. Either EpCAM or cadherin-11 transmembrane receptors were targeted to selectively capture target cells from the suspensions. Cadherin-11-expressing MDA-MB-231 cancer cells were used as target cells, while BT-20 cells were used as non-target cells as they do not express cadherin-11. The attachment and detachment of these two cell lines are characterized, and a two-step attachment/detachment flow field pattern is implemented to enhance the system performance in capturing target cells from binary mixtures. While the system sensitivity remains high, above 0.95, the specificity increases from about 0.85 to 0.95 solely due to the second detachment step even for a 1 : 1000 relative concentration of the target cells.

Citing Articles

Application of Microfluidic Systems for Breast Cancer Research.

Frankman Z, Jiang L, Schroeder J, Zohar Y Micromachines (Basel). 2022; 13(2).

PMID: 35208277 PMC: 8877872. DOI: 10.3390/mi13020152.


Cellulose Mediated Transferrin Nanocages for Enumeration of Circulating Tumor Cells for Head and Neck Cancer.

Hazra R, Kale N, Aland G, Qayyumi B, Mitra D, Jiang L Sci Rep. 2020; 10(1):10010.

PMID: 32561829 PMC: 7305211. DOI: 10.1038/s41598-020-66625-2.


Optimizing Circulating Tumor Cells' Capture Efficiency of Magnetic Nanogels by Transferrin Decoration.

Biglione C, Bergueiro J, Asadian-Birjand M, Weise C, Khobragade V, Chate G Polymers (Basel). 2019; 10(2).

PMID: 30966210 PMC: 6414968. DOI: 10.3390/polym10020174.


Applications of Nanosheets in Frontier Cellular Research.

Huang W, Sunami Y, Kimura H, Zhang S Nanomaterials (Basel). 2018; 8(7).

PMID: 30002280 PMC: 6070807. DOI: 10.3390/nano8070519.


Tumor cell capture patterns around aptamer-immobilized microposts in microfluidic devices.

Chen K, Georgiev T, Sheng W, Zheng X, Varillas J, Zhang J Biomicrofluidics. 2017; 11(5):054110.

PMID: 29034054 PMC: 5624804. DOI: 10.1063/1.5000707.


References
1.
Cristofanilli M, Budd G, Ellis M, Stopeck A, Matera J, Miller M . Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004; 351(8):781-91. DOI: 10.1056/NEJMoa040766. View

2.
Troyanovsky S . Mechanism of cell-cell adhesion complex assembly. Curr Opin Cell Biol. 1999; 11(5):561-6. DOI: 10.1016/s0955-0674(99)00021-6. View

3.
Braun S, Hepp F, Kentenich C, Janni W, Pantel K, Riethmuller G . Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow. Clin Cancer Res. 2000; 5(12):3999-4004. View

4.
Prang N, Preithner S, Brischwein K, Goster P, Woppel A, Muller J . Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell lines. Br J Cancer. 2005; 92(2):342-9. PMC: 2361858. DOI: 10.1038/sj.bjc.6602310. View

5.
Wheelock M, Johnson K . Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol. 2003; 19:207-35. DOI: 10.1146/annurev.cellbio.19.011102.111135. View